OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
Stéphanie Andrade, Débora Nunes, Meghna Dabur, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 212-212
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review
Jinjin Pei, Chella Perumal Palanisamy, Prabhu Manickam Natarajan, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102393-102393
Closed Access | Times Cited: 8

Natural flavonoids as potential therapeutics in the management of Alzheimer’s disease: a review
Phuong‐Trang Nguyen‐Thi, Tuong Kha Vo, Thi Hong Trang Pham, et al.
3 Biotech (2024) Vol. 14, Iss. 3
Closed Access | Times Cited: 7

The development of nanocarriers for natural products
Liying Huang, Shicui Luo, Sen Tong, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 3
Closed Access | Times Cited: 6

Rotenone Induces a Neuropathological Phenotype in Cholinergic-like Neurons Resembling Parkinson’s Disease Dementia (PDD)
Daniela Giraldo-Berrio, Miguel Mendivil‐Perez, Carlos Velez‐Pardo, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 3
Open Access | Times Cited: 6

Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer’s pathologies?
Sushmitaa Dhevii Manoharan, Hafizah Abdul Hamid, Nur Fariesha Md Hashim, et al.
Brain Research (2024) Vol. 1829, pp. 148793-148793
Closed Access | Times Cited: 4

Neuroprotective insights into epigallocatechin gallate (EGCG) for neurodegenerative disorders
Neha Kamboj, S.D. Sharma, Rahul Kumar
Exploration of neuroscience (2025)
Open Access

Drugging Disordered Proteins by Conformational Selection to Inform Therapeutic Intervention
Bryan A. Bogin, Zachary A. Levine
Journal of Chemical Theory and Computation (2025)
Open Access

Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer’s Disease
Paola Gualtieri, Giulia Frank, Rossella Cianci, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 922-922
Open Access

Natural products in neurodegenerative diseases: recent advances and future outlook
Lutfun Nahar, Rawiwan Charoensup, Kulyash Kalieva, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Phytochemicals Modulate Biosynthesis and Function of Serotonin, Dopamine, and Norepinephrine for Treatment of Monoamine Neurotransmission-Related Psychiatric Diseases
Makoto Naoi, Yuqiu Wu, Wakako Maruyama, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2916-2916
Open Access

Virtual screening and molecular dynamics of anti-Alzheimer compounds from Cardiospermum halicacabum via GC-MS
Selvan Kaviyarasu, Nallamuthu Padmanaban, Sulekha Khute, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access

Cannabidiol Protects Dopaminergic-like Neurons against Paraquat- and Maneb-Induced Cell Death through Safeguarding DJ-1CYS106 and Caspase 3 Independently of Cannabinoid Receptors: Relevance in Parkinson’s Disease
Miguel Mendivil‐Perez, Andrea A. Felizardo-Otalvaro, Marlene Jiménez-Del-Río, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2159-2171
Closed Access | Times Cited: 10

Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases
Lingzhi Xiang, Yanan Wang, Shenkui Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11275-11275
Open Access | Times Cited: 9

Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models
Carlos Franciney Moreira Vasconcelos, Agnieszka Zofia Neugebauer, Ricardo Basto Souza
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 6, pp. 770-777
Open Access | Times Cited: 3

Retrolaminar Demyelination of Structurally Intact Axons in Nonhuman Primate Experimental Glaucoma
Priya Chaudhary, Howard Lockwood, Cheri Stowell, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 2, pp. 36-36
Open Access | Times Cited: 1

Immunosuppressive phytochemicals and phytonutrients in plants in Nigeria: a systematic review
Mathew Folaranmi Olaniyan, Olufemi David Olaniyi, Tolulope Busayo Ojediran, et al.
Discover Immunity. (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1

Advancing Nutraceuticals in a Promising Frontier in Modern Healthcare
Flora Shah, Karuppiah Nagaraj, S. Kamalesu, et al.
Food and Humanity (2024), pp. 100462-100462
Closed Access | Times Cited: 1

A Novel Resveratrol-Induced Pathway Increases Neuron-Derived Cell Resilience against Oxidative Stress
Patrizio Cracco, Emiliano Montalesi, Martina Parente, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5903-5903
Open Access | Times Cited: 3

Drugging Disordered Proteins by Conformational Selection to Inform Therapeutic Intervention
Bryan A. Bogin, Zachary A. Levine
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

Computational Analysis to Elucidate Parkinson's Disease Pathophysiology and Therapeutics
Devesh Srivastava, Ashish Misra
(2024) Vol. 29, pp. 1-6
Closed Access

Exploring the therapeutic implications of natural compounds modulating apoptosis in vascular dementia
Guangcheng Zhong, Xinyue Wang, Qian Zhang, et al.
Phytotherapy Research (2024)
Closed Access

Two-step emulsification for the fabrication of homogeneous PCL microspheres encapsulating geniposidic acid with antioxidant properties
Hongyu Wang, Peng Ye, Ran Song, et al.
Particuology (2024) Vol. 94, pp. 305-313
Closed Access

The potential therapeutic strategy in combating neurodegenerative diseases: Focusing on natural products
Li Gao, Ximing J. Yang, Yixiao Dong, et al.
Pharmacology & Therapeutics (2024) Vol. 264, pp. 108751-108751
Closed Access

Page 1 - Next Page

Scroll to top